Taken together, these concordant findings in multiple mouse models of T-ALL demonstrate that tumor-associated myeloid cells promote T-ALL survival and growth via activation of integrin signaling and downstream FAK/PYK2 kinases. Here, PTK2 is linked to neoplasm.